\n
COVID-19 disrupted medical device supply chains, stressing the availability of essential medical devices and active pharmaceutical ingredients, particularly those reliant on suppliers in China and India.<\/p>\n<\/p><\/div>\n<\/details>\n\nHow is regulatory compliance evolving in response to the pandemic?<\/summary>\n\n
Regulators have introduced temporary accommodations to facilitate the availability of medical therapies and devices, including Emergency Use Authorizations (EUAs) and relaxed assessment procedures.<\/p>\n<\/p><\/div>\n<\/details>\n\nWhat trends are emerging in regulatory outsourcing?<\/summary>\n\n
The regulatory affairs outsourcing market is projected to grow significantly, reflecting a shift towards leveraging external expertise to ensure compliance and operational agility during instability.<\/p>\n<\/p><\/div>\n<\/details>\n\nWhat challenges do manufacturers face with supply chain shifts?<\/summary>\n\n
Shifting manufacturing locations introduces new regulatory complexities that require RA\/QA professionals to reassess compliance requirements for different jurisdictions.<\/p>\n<\/p><\/div>\n<\/details>\n\nWhat was the original deadline for the EU Medical Device Regulation (EU MDR)?<\/summary>\n\n
The EU MDR was originally set to take effect on May 26, 2020, but this was delayed to May 26, 2021, due to pandemic-related pressures.<\/p>\n<\/p><\/div>\n<\/details>\n\nHow does the EU MDR impact combination products?<\/summary>\n\n
The EU MDR subjects the ancillary medical device components of combination products to the same scrutiny as standalone medical devices, increasing regulatory burdens on pharmaceutical companies.<\/p>\n<\/p><\/div>\n<\/details>\n\nWhat initiatives is the FDA proposing to address medical product shortages?<\/summary>\n\n
The FDA proposed measures to enhance drug expiration date management, improve risk assessments, and bolster authority over medical device shortages to mitigate supply chain vulnerabilities.<\/p>\n<\/p><\/div>\n<\/details>\n\nWhat is the role of managed outsourcing platforms in regulatory compliance?<\/summary>\n\n
Managed outsourcing platforms can help companies achieve compliance and scalability by providing immediate access to specialized expertise and support during dynamic regulatory environments.<\/p>\n<\/p><\/div>\n<\/details>\n\nWhat are the implications of the EU In Vitro Diagnostic Regulation (IVDR)?<\/summary>\n\n
The IVDR, effective May 26, 2022, introduces stricter regulations for in vitro diagnostics, including new definitions for companion diagnostics that pharmaceutical companies must comply with.<\/p>\n<\/p><\/div>\n<\/details>\n\nWhy is business agility crucial for life sciences companies?<\/summary>\n\n
Business agility enables life sciences companies to swiftly adapt to evolving regulatory landscapes, ensuring continuity of supply and compliance with regulatory obligations amidst new challenges.<\/p>\n<\/p><\/div>\n<\/details><\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"
The COVID-19 pandemic has significantly affected many sectors, especially healthcare, impacting the medical device supply chain. Medical practice administrators, owners, and IT managers in the United States have experienced these disruptions and recognized the importance of effective supply chain management. This article discusses how COVID-19 affected medical device supply chains and offers strategies to mitigate […]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-27130","post","type-post","status-publish","format-standard","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/posts\/27130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/comments?post=27130"}],"version-history":[{"count":0,"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/posts\/27130\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/media?parent=27130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/categories?post=27130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.simbo.ai\/blog\/wp-json\/wp\/v2\/tags?post=27130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}